Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.66 |
| ▸ | MMP1 | P03956 | 1/20 | 0.66 |
| ▸ | FOS | P01100 | 1/20 | 0.65 |
| ▸ | TTR | P02766 | 1/20 | 0.65 |
| ▸ | JUN | P05412 | 1/20 | 0.65 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.65 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.65 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | GLA | P06280 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.62 |
| ▸ | AR | P10275 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vanillyl Alcohol SCHEMBL62348 | 1.00 | TAAR1 (0.67) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL27774687 | 1.00 | TAAR1 (0.67) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL116860 | 0.98 | TAAR1 (0.65) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL2238547 | 0.96 | TAAR1 (0.62) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL19742906 | 0.91 | TSHR (0.58) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL579759 | 0.91 | TAAR1 (0.57) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL29092590 | 0.91 | TAAR1 (0.57) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL118233 | 0.89 | FOS (0.63) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL117923 | 0.88 | TAAR1 (0.54) | TAAR1TSHRMAPK1CYP3A4MMP1 | |
| Vanillyl Alcohol SCHEMBL28478856 | 0.88 | TSHR (0.55) | TAAR1TSHRMAPK1CYP3A4MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| EP-4251708-B1 | METHOD FOR PRODUCING A HIGH-PHENOLIC-CONTENT BIOOIL | THE UNIV OF NEW BRUNSWICK (CA) | 2026-02-11 | — | — | EP | disclosed |
| EP-4680039-A1 | COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF | DSM-Firmenich AG (CH) | 2026-01-21 | — | — | EP | disclosed |
| EP-4615958-A1 | CELL COMPOSITIONS | Givaudan SA (CH) | 2025-09-17 | — | — | EP | disclosed |
| EP-4603580-A1 | METHOD OF BIOTECHNOLOGICAL VANILLIN OR 4-VINYLGUAIACOL PRODUCTION | Phytowelt Green Technologies GmbH (DE) | 2025-08-20 | — | — | EP | disclosed |
| EP-4572795-A2 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS | The University of Chicago (US) | 2025-06-25 | — | — | EP | disclosed |
| EP-4561360-A1 | ROBUST FLAVOR EMULSIONS | International Flavors & Fragrances Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-119522254-A | Fibrous cellulose composite resin, fibrous cellulose-containing material, and method for producing fibrous cellulose composite resin | 大王制纸株式会社 | 2025-02-25 | — | — | CN | disclosed |
| CN-119403886-A | Fibrous cellulose composite resin | 大王制纸株式会社 | 2025-02-07 | — | — | CN | disclosed |
| WO-2024251755-A1 | COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF | DSM-FIRMENICH AG (CH) | 2024-12-12 | — | — | WO | disclosed |
| WO-2022198088-A1 | MODIFIED HOST CELLS FOR HIGH EFFICIENCY PRODUCTION OF VANILLIN | Amyris, Inc. (US) | 2022-09-22 | — | — | WO | disclosed |
| EP-4007815-A1 | MODIFIED HOST CELLS FOR HIGH EFFICIENCY PRODUCTION OF VANILLIN | Amyris, Inc. (US) | 2022-06-08 | — | — | EP | disclosed |
| EP-4007748-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2022-06-08 | — | — | EP | disclosed |
| CN-114502704-A | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2022-05-13 | — | — | CN | disclosed |
| WO-2022081133-A1 | MODIFIED POROUS WICKING MEMBRANES | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-04-21 | — | — | WO | disclosed |
| WO-2022076334-A2 | CLEANING COMPOSITION COMPRISING AN ALPHA-DIOXYGENASE | THE PROCTER & GAMBLE COMPANY (US) | 2022-04-14 | — | — | WO | disclosed |
| EP-3976061-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-TARGETED ADJUVANTS | The University of Chicago (US) | 2022-04-06 | — | — | EP | disclosed |
| WO-2022060867-A1 | CULTURE COMPOSITIONS AND METHODS OF THEIR USE FOR HIGH YIELD PRODUCTION OF VANILLIN | Amyris, Inc. (US) | 2022-03-24 | — | — | WO | disclosed |
| CN-114174489-A | Modified host cells for efficient production of vanillin | 阿迈瑞斯公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20220064114-A1 | PHENALENE-1-ONE-CONTAINING PHOTOSENSITIZER COMPOSITION, PHENALENE-1-ONE COMPOUND AND THE USE THEREOF | TRIOPTOTEC GMBH (DE) | 2022-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064114-A1 | PHENALENE-1-ONE-CONTAINING PHOTOSENSITIZER COMPOSITION, PHENALENE-1-ONE COMPOUND AND THE USE THEREOF | PYCR1, CRY1, PPOX | TAAR1 2844/4885TSHR 4876/4885MAPK1 1335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.